Abstract: Stable formulations of positively charged, hydrolytically unstable drug compounds are obtained by adding a sulfated polyvinyl alcohol copolymer to the formulations.
Type:
Grant
Filed:
November 21, 1994
Date of Patent:
September 2, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Ernesto J. Castillo, Yusuf Ali, Ruma P. Sarkar
Abstract: A fiberoptic illumination system having an attenuator with a "multiple wedge" aperture that more uniformly attenuates the light beam striking the fiberoptic without changing the color temperature of the light beam or affecting the exit divergence angle of the light beam. The system includes an optical housing design having orthogonal lights paths that allows two fiberoptics to be illuminated from the same bulb, two bulbs located in primary and back-up positions, respectively, mounted on a rotating carousel and a retinal protection filter that filters out wavelengths of light harmful to the retina.
Type:
Grant
Filed:
October 27, 1994
Date of Patent:
August 19, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
T. Scott Rowe, Eric Marason, David Wilkinson
Abstract: Disclosed are storage-stable preserved ophthalmic compositions containing acidic drugs in combination with polymeric quaternary ammonium compounds and boric acid.
Abstract: Compositions and methods are provided for cleaning and wetting of contact lenses, especially rigid, gas-permeable contact lenses. The compositions comprise low molecular weight polyalkylene oxide modified siloxanes, which are particularly effective in removing lipids from the surface of contact lenses.
Type:
Grant
Filed:
March 14, 1995
Date of Patent:
August 5, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Nayan N. Desai, Ronald P. Quintana, Masood A. Chowhan
Abstract: Compounds structurally related to ethacrynic acid are described. The compounds are useful for controlling intraocular pressure. Unlike ethacrynic acid, the compounds of the present invention are capable of effectively penetrating the cornea. Methods of controlling intraocular pressure via topical application of one or more of the compounds to the eye and topical ophthalmic compositions useful in the treatment of glaucoma are also described.
Abstract: New thiophene sulfonamides useful as carbonic anhydrase inhibitors are disclosed. Methods for using the compounds to control IOP are also disclosed.
Type:
Grant
Filed:
July 8, 1994
Date of Patent:
July 8, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Anura P. Dantanarayana, Thomas R. Dean, Jesse A. May
Abstract: A phacoemulsification sleeve having a centering ring isolated within an outer shell. A bellows-like sleeve between the handpiece and the outer shell provides a fluid path for the irrigating fluid.
Abstract: Polyethylene oxide (PEO) coatings providing improved biocompatibility for implantable medical devices are disclosed. The PEO coatings comprise functionalized end-capped PEO which is attached at one end to the medical device. The PEO compounds are then exposed to a high energy source for a time sufficient to cause the PEO compounds to form a cross-linked, insoluble network. These PEO coatings am able to survive ethylene oxide sterilization procedures with minimal loss of protein or cell repulsion ability.
Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
July 8, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Mark R. Hellberg, George Barnes, Robert J. Collier, Jr.
Abstract: Methods for treating vascular inflammatory pathologies are disclosed. Particularly, the methods utilize pharmaceutical compositions containing certain compounds having an anti-inflammatory and anti-oxidant moiety covalently linked by an amide or ester bond. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
July 1, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Daniel A. Gamache, Mark R. Hellberg, Jon C. Nixon, Gustav Graff
Abstract: Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
Abstract: A lens storage container having an interior coated with an enzymatic cleaning composition useful for cleaning and disinfecting contact lenses.
Abstract: An infusion sleeve having a two-piece body. The first piece is conical in shape and is attached to the handpiece by conventional methods. The distal end of the first piece contains a series of annular grooves. The second piece is tubular in shape and contains an annular rim or lip on the proximal end that interlocks within the annular grooves on the first piece.
Abstract: Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when indicated for control and lowering of intraocular pressure.
Abstract: The use of certain amidoamines to disinfect contact lenses and preserve ophthalmic compositions is described. Ophthalmic compositions containing these compounds as disinfecting agents or preservatives are also described. The amidoamines utilized in the present invention have potent antibacterial and antifungal activity, and are chemically compatible with inorganic ions and other materials utilized in ophthalmic compositions.
Type:
Grant
Filed:
February 24, 1995
Date of Patent:
May 20, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Nissanke L. Dassanayake, Ronald L. Schlitzer, Joonsup Park
Abstract: An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painful and potentially traumatic injections of antibiotics by utilizing sustained release compositions which allow the antibiotics contained therein to penetrate deeply into the eye, thereby ensuring a sterile field of surgery during intraocular surgical procedures. The compositions may also be utilized to prevent post-surgical infections.
Type:
Grant
Filed:
September 30, 1993
Date of Patent:
May 20, 1997
Assignee:
Alcon Laboratories, Inc.
Inventors:
Gerald D. Cagle, Tai-Lee Ke, Barry A. Schlech, Ole J. Lorenzetti